The acting head of the Food and Drug Administration is calling for a government investigation into highly unusual contacts between her agency’s drug reviewers and the maker of a controversial new Alzheimer’s drug
Related posts
-
‘So empowering’: Community blossoms through inclusive art project in Roselle
A Roselle sculpture project celebrates artists with special needs. -
United celebrates, American sues as city updates gate allocation at O’Hare
Who’s on first at O’Hare International Airport? Here’s a look at Chicago’s gate update as United... -
Why your ComEd bills are going up this month
Residential ComEd customers in Illinois will pay more for electricity starting this month, the utility confirmed...